TrialDrugs in R&D2022

Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease.

Liangying Gan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.